Key takeaway
Among 118 men and 46 women aged 61 to 90 at a Tianjin hospital, those with sarcopenia had higher levels of the inflammatory cytokine IL-6, the anti-inflammatory cytokine IL-10 and a higher IL-6/IL-10 ratio, even after adjustment. The comparison is a one-time snapshot in a small hospital check-up group, so it cannot show that inflammation causes muscle loss.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
The biological causes of sarcopenia, the age-related loss of muscle mass and function, are not fully understood. The authors asked whether blood levels of interleukin-6 (IL-6, which promotes inflammation) and interleukin-10 (IL-10, which dampens it) differ between older people with and without sarcopenia.
Who and how
Cross-sectional study of 118 men and 46 women aged 61 to 90 who had a general medical examination at Tianjin First Central Hospital. Sarcopenia was defined by the Asian Working Group for Sarcopenia (AWGS) criteria, and participants were split into sarcopenia and non-sarcopenia groups. The groups were compared on body composition, handgrip strength, gait speed, blood biochemistry, IL-6 and IL-10, lifestyle and disease status, using univariate and then adjusted regression. The abstract does not report group sizes or effect sizes.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1People without sarcopenia exercised more regularly. Those with sarcopenia were older, had higher nutrition risk and more visceral fat, and had lower body mass index (BMI), serum albumin, triglyceride and creatinine.
- 2IL-6 and IL-10 levels, and the IL-6/IL-10 ratio, were higher in the sarcopenia group (P < 0.05).
- 3After adjusting for confounders, sarcopenia was positively correlated with IL-6, IL-10 and the IL-6/IL-10 ratio and inversely correlated with BMI. Age was associated with a higher chance of having sarcopenia.
- 4The abstract gives no odds ratios, confidence intervals or exact levels, so the size of these associations cannot be judged.
Limits & uncertainty
- 1A single measurement in hospital check-up attendees cannot show whether inflammation precedes muscle loss or follows it.
- 2With participants from one hospital only, the sample is small and may not reflect other older populations.
- 3Higher IL-10 alongside higher IL-6 is hard to interpret, and the abstract offers no explanation of the mechanism.
- 4This reading is based on the abstract only, and the adjustment variables are not listed.
What to take from it
Sarcopenia in this group went along with raised inflammatory markers, regular exercise being less common and lower BMI, but the study cannot say which came first. Cytokine blood tests are not a routine way to check muscle health, and concerns about weakness should go to your clinician.
Reading your own data
Inflammatory cytokines are not something you can track at home. What you can follow are exercise habits, grip strength if you have a dynamometer, walking speed and weight trends, compared against your own earlier values using the same device or scale.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background and objectives
The pathophysiological mechanism of sarcopenia in the elderly has not yet been fully understood. Here, we aim to explore the relationship between sarcopenia and the inflammatory cytokine interleukin-6 (IL-6), and the anti-inflammatory cytokine interleukin-10 (IL-10) in an elderly population.
Methods
Our study comprised 118 males and 46 females aged between 61 and 90 who had received a general medical examination in Tianjin First Central Hospital. Subjects were divided into a sarcopenia group and a non-sarcopenia group, defined according to the criteria of the Asian Working Group for Sarcopenia (AWGS). We compared body composition, handgrip strength (HS), gait speed (GS), biochemical indexes, levels of IL-6 and IL-10, living habits, and disease status between these groups.
Results
Non-sarcopenia subjects undertook more regular physical exercise than sarcopenia patients. Sarcopenia subjects had higher nutrition risk but lower body mass index (BMI), serum albumin (ALB), triglyceride (TG), and creatinine (Cr) levels compared to non-sarcopenia subjects. Sarcopenia subjects were older and had higher visceral fat tissue (VFA) than non-sarcopenia subjects (P < 0.05), along with higher IL-6 and IL-10 levels. Furthermore, IL-6/IL-10 ratios were higher in subjects with sarcopenia (P < 0.05). Age, BMI, levels of physical activity, nutritional risk, VFA, IL-6, IL-10, IL-6/IL-10 ratio were independently associated with the presence of sarcopenia in univariate regression analyses. Following adjustment for confounding factors, the presence of sarcopenia was positively correlated with IL-6, IL-10, IL-6/IL-10 ratio and inversely correlated with BMI. Age is associated with increased presence of sarcopenia.
Conclusions
The levels of inflammation cytokine IL-6, anti-inflammatory IL-10 and IL-6/IL-10 ratio were increased in elderly sarcopenia subjects. Sarcopenia was associated with increased levels of inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10, and IL-6/IL-10 ratios.
Sources & attribution
Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10.
Rong YD, Bian AL, Hu HY, Ma Y, Zhou XZ.
BMC geriatrics · 2018-12-12
DOI: 10.1186/s12877-018-1007-9 ↗PubMed · 30541467 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

